site and a stop codon (5 ′ -GC TCTAGA TTA CCACTGTGCACTG-AGTGGA-3 ′ ). These fragments were cloned into the Not I-Xba I sites of p3xFLAG-CMV-10 (Sigma-Aldrich).
For expression in Escherichia coli , a DNA fragment encoding mouse WT ACOT12 was prepared by PCR using a forward primer containing an Xho I site (5 ′ -CCG CTCGAG AT GGAGTCGATGG-TGGCGCCG-3 ′ ) and a reverse primer containing an Xba I site (5 ′ -GC TCTAGA TTATAACACACTTTTAAGTCCA-3 ′ ) using ACOT12 cDNA cloned into pcDNA3.1/V5-His. A DNA fragment encoding the THIO (Met1-Trp344) was amplifi ed using the same forward primer and a reverse primer containing an Xba I site (5 ′ -GC TCTAGA TTACCACTGTGCACTGAGTGGA-3 ′ ). A DNA fragment encoding the START domain (Asp345-Leu556) was amplifi ed using a forward primer containing an Xho I site (5 ′ -CCG-CTCGAG GATATAAGCAAAAAGGGATCC-3 ′ ) and the same reverse primer used for WT amplifi cation. The DNA fragments were cloned into the Xho I-Xba I sites of a bacterial expression vector, pColdDNAI (Novagen, Madison, WI). The vectors were constructed with insertions of 6×His-Tag at an N terminus of expressed proteins. Nucleotide sequences were confi rmed using the BigDye Terminator Cycle Sequencing kit (Applied Biosystems) and a DNA sequencer (ABI PRISM 377-XL, Applied Biosystems).
The insert-containing vectors were then transformed into E . coli strain JM109 and grown at 37°C to an O.D. A 600 of 0.5 in 200 ml of Luria-Bertani broth supplemented with 50 g/ml ampicillin. Next, protein expression was induced by the addition of 0.1 mM isopropyl ␤ -D-thiogalactopyranoside followed by incubation for 20 h at 15°C. Subsequently, cells were collected, resuspended, and sonicated in 10 ml of 50 mM Tris-HCl buffer, pH 8.0, containing 0.5 mM phenylmethylsulfonyl fl uoride (PMSF). The protein purifi cation was performed at room temperature to avoid cold inactivation ( 20 ) . After removing cell debris by centrifugation at 10,000 g for 10 min, the supernatant was applied to a NTF Sepharose column (GE Healthcare Bio-Sciences Corp., Uppsala, Sweden). The expressed His-tagged proteins were adsorbed and eluted with 20 mM Tris-HCl buffer, pH 8.0, containing 500 mM imidazole. Imidazole was then removed by applying the purifi ed proteins to a PD-10 column (BioRad, Hercules, CA) and the proteins were eluted with 20 mM Tris-HCl buffer, pH 8.0, containing 150 mM NaCl. Purifi ed protein was stored in 5 l aliquots at Ϫ 80°C and thawed immediately prior to use.
Acetyl-CoA hydrolase activity
Acetyl-CoA thioesterase activity was measured on a Model 680 microplate reader (BioRad) using DTNB. Briefl y, acetyl-, acetoacetyl-, butyryl-, octanoyl-, or HMG-CoA at 1 mM or another concentration (as indicated) was incubated at 37°C for the indicated time with an appropriate amount of tag-purifi ed enzyme (25-120 ng) in 50 l of 20 mM Tris-HCl buffer, pH 8.0, containing 150 mM NaCl, 1 mM ATP, and 1 mM DTNB. Immediately following, the absorbance of the reaction mixture at 415 nm was analyzed using a spectrophotometer. To analyze the effects of phospholipids, fatty acids, or sphingolipids on enzyme activity, the lipids were dissolved in chloroform, dried under nitrogen, dissolved in 20 mM Tris-HCl buffer, pH 8.0, containing 150 mM NaCl, and sonicated using a probe-type sonicator. Sterols were dissolved in the same buffer containing 3 mM hydroxypropyl-␤ -cyclodextrin (fi nal concentration).
Binding assay for phospholipid-conjugated beads
Phospholipid-conjugated butyl-Sepharose beads were prepared as described previously ( 21 ) with some modifi cations. Briefl y, a clear suspension of DOPC or DOPA (0.5 mM) was formed by dissolving each in Tris-buffered saline (TBS) using a probe-type sonicator. Next, butyl-Sepharose equilibrated with TBS (200 l) was residues thought to act as a lipid binding, transferring, and sensing domain for phospholipids, sterols, and sphingolipids (16) (17) (18) (19) . There are 15 distinct human proteins containing START domains, termed StarD1-StarD15. The lipids or sterols bound by nine of the START domaincontaining proteins (StarD1-7, -10, and -11) have been identifi ed ( 16, 18 ) . In contrast, neither lipid ligands nor the biological signifi cance of the START domains of six other START proteins (StarD8, -9, and -12-15), including ACOT12 (StarD15), are known.
Because ACOT12 appears to be the major enzyme responsible for determining the rate of degradation of cytosolic acetyl-CoA in the liver, the enzymatic regulation of ACOT12 is important for the control of lipid biosynthesis. In this study, we found that acetyl-CoA hydrolase activity of ACOT12 can be inhibited by phosphatidic acid (PA) and lysophosphatidic acid (LPA). Furthermore, the START domain in ACOT12 plays an important role in inhibition. We also report that in rat primary hepatocytes, ACOT12 mRNA and protein levels are downregulated following treatment with insulin. These results suggest that acetylCoA levels for lipid biosynthesis are regulated by lipid metabolites and hormones via control of the enzymatic activity and transcription of ACOT12.
MATERIALS AND METHODS

Biochemicals
Egg yolk PA and soybean phosphatidylinositol were obtained from Nacalai Tesque (Kyoto, Japan). Insulin, 1-oleoyl LPA, glycerol 3-phosphate (G3P), oleoyl-CoA, acetoacetyl-CoA, and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) were purchased from SigmaAldrich (St. Louis, MO). Dioleoyl phosphatidic acid (DOPA); dioleoyl phosphatidylcholine (DOPC); 1-stearoyl, 2-oleoylphosphatidylcholine (PC); 1-stearoyl, 2-oleoyl-phosphatidylserine; 1-stearoyl, 2-oleoyl-phosphatidylethanolamine (PE); and dimyristoyl phosphatidylglycerol (DMPG) were obtained from Avanti Polar Lipids (Alabaster, AL). Acetyl-CoA, clofi brate, and 5,5 ′ -dithiobis-2-nitrobenzoic acid (DTNB) were obtained from Wako Pure Chemicals (Tokyo, Japan). Butyryl (C4)-CoA and octanoyl (C8)-CoA were from DOOSAN Serdary Research Laboratories (Seoul, Korea). All reagents used were of the highest purity available.
Expression and purifi cation of ACOT12
To obtain the V5-tagged constructs for expression in mammalian cells, a DNA fragment encoding mouse wild-type (WT) ACOT12 (GenBank accession number NM_028790) was prepared by PCR using a forward primer (5 ′ -ATGGAGTCGATGGTGGCGCCGGG-TGAGGTG-3 ′ ) and a reverse primer (5 ′ -TAACACACTTTTAAG-TCCATCAGGAGTAGC-3 ′ ) using mouse cDNA library as template. A DNA fragment encoding the thioesterase domain (THIO) was amplifi ed using the same forward primer and a reverse primer (5 ′ -CCACTGTG CACTGAGTGG AACTTC TTT CTT-3 ′ ). These fragments were cloned into pcDNA3.1/V5-His (Invitrogen, Carlsbad, CA). To obtain the 3xFlag-tagged constructs, a DNA fragment encoding WT was amplifi ed by PCR using a forward primer containing an Not I site (5 ′ -ATTT GCGGCCGC GATGGAGTCGATG-GTGGCGCC-3 ′ ) and a reverse primer containing an Xba I site and a stop codon (5 ′ -GC TCTAGA TTA TA AC ACAC TTTTAAGTCCA-3 ′ ). A DNA fragment encoding the THIO was amplifi ed using the same forward primer and a reverse primer containing an Xba I by guest, on November 9, 2017 www.jlr.org 10 g/ml of leupeptin, pepstatin, and chymostatin at room temperature. After centrifugation at 25,000 g for 15 min, 3xFlag-tagged protein was immunoprecipitated using anti-Flag M2 affi nity gel (Sigma-Aldrich) at room temperature. The immunoprecipitated protein complex was washed fi ve times with TBS to remove any remaining detergent completely, and then incubated with or without 100 M of DOPA in TBS at room temperature, or with TBS on ice for 1 h. The proteins bound to the gel or released into the supernatants were separated by centrifugation at 3,000 g for 5 min and analyzed by immunoblotting using anti-V5 (Invitrogen) or anti-Flag (Sigma-Aldrich) antibody.
Primary culture of rat hepatocytes and quantitative PCR
Hepatocytes were isolated from Wistar rats using a modifi ed two-step collagenase perfusion in situ ( 23 ) . To do this, cells were plated at 2 × 10 4 cells/0.25 ml/cm 2 in collagen (type I)-coated 12-well plates (Asahi Glass Co., Japan) and cultured in Williams' medium E (Sigma-Aldrich) supplemented with 10% FBS (Invitrogen), 100 units/ml penicillin, 100 g/ml streptomycin, 1 M dexamethasone, and 1 M insulin under 5% CO 2 at 37°C. Four hours after plating the cells, the medium was replaced with Williams' medium E without dexamethasone and insulin, and cells were cultured in the presence or absence of 10% FBS for the number of days indicated. The culture medium was changed daily. To analyze the effects of insulin and clofi brate, cells plated as described above were cultured in the absence of FBS, dexamethasone, and insulin for 20 h, then cells at day 1 were cultured with or without insulin (100 nM) or clofi brate (100 M) for 2-10 h. Total RNA was collected using RNA extraction kits (Qiagen, Valencia, CA) according to the manufacturer's instructions. To quantify the mRNA levels for ACOT12 and ␤ -actin, total RNA was reverse-transcribed at 37°C for 15 min using PrimeScript™ reverse transcriptase (Takara Bio Inc., Shiga, Japan) and then subjected to 40 cycles of amplifi cation (7300 Real Time PCR System, Applied Biosystems, Indianapolis, IN) using a FastStart Universal SYBR Green Master (Roche). ␤ -actin was used as an internal control for the verifi cation of ACOT12. The following primers were used for quantitative PCR: 5 ′ -CATGGCGTGGATGGAGACA-3 ′ /5 ′ -TTGACGATGGCATTGAAGACAAG-3 ′ for rat ACOT12; 5 ′ -GACTCATCGTACTCCTGCTTGCTG-3 ′ /5 ′ -GGAGATTACTGCC C TGGCTCCTA-3 ′ for rat ␤ -actin.
HepG2 cells were cultured in DMEM with 10% FBS. Fa2N-4 cells were purchased from XenoTech LLC (Lenexa, KS) and cultured in MFE support medium according to the manufacturer's instructions.
RESULTS
Expression and oligomerization of recombinant proteins
Protein constructs used in this study are shown in Fig. 1A . cDNA fragments encoding mouse WT ACOT12 (556 amino residues), the THIO (Met1-Trp344), or the START domain (Asp345-Leu556) were expressed in E. coli , then purifi ed using a Ni-Sepharose column ( Fig. 1B ) .
As shown in Fig. 2A , the thioesterase activities of WT and THIO increased i n a nearly linear manner, dependent upon the amount of purifi ed protein. Figure 2 panels B and C show a time course of the hydrolysis of acetyl-CoA at various concentrations by WT (25 ng) and THIO (120 ng). The thioesterase reactions proceeded linearly up to 15 min and then enzyme activities were saturated via a 60 min incubation with 1 mM acetyl-CoA. To determine the initial velocity rate for hydrolysis of CoA compounds by the purifi ed combined with the phospholipid solutions (800 l, 400 nmol). After incubation for 1 h with shaking, the slurry was extensively washed with TBS, and then with 5 vol of TBS containing 0.05% Triton X-100. The amount of phospholipids conjugated to the gel was quantifi ed by measuring inorganic phosphorous following perchloric acid digestion ( 22 ) . In this procedure, about 300 nmol of phospholipids (75% of phospholipids added) were conjugated with 200 l of the gel. When G3P was used instead of phospholipids, about 30 nmol of G3P (10% of G3P added) were conjugated to the beads, indicating that fatty acid chains in phospholipids are important for binding to the gel. Purifi ed WT, THIO, or START proteins were mixed with PC-or PA-conjugated beads and incubated for 30 min at room temperature to allow for binding. Proteins bound to the beads or remaining in the supernatants were separated by centrifugation at 3,000 g for 5 min. The proteins bound to the lipid-conjugated beads were then extracted by boiling in SDS-PAGE sample buffer. Proteins from both fractions were analyzed by immunoblotting using an anti-ACOT12 antibody. To assess the effect of acetyl-CoA on ACOT12-DOPA interaction, ACOT12-bound DOPA gel was incubated with the indicated concentrations of acetyl-CoA in TBS containing 0.05% Triton X-100 for 30 min. After centrifugation, proteins in the supernatant and precipitated fractions were analyzed as described above.
Antibody and immunoblot analysis
Anti-ACOT12 serum was prepared by injection of 0.5 mg of the purifi ed ACOT12 protein four times into a New Zealand White rabbit. Preimmune serum was obtained before immunization and used as a negative control. To perform immunoblot analysis, proteins were fi rst separated by SDS-PAGE and then transferred to nitrocellulose membranes using a semi-dry electroblotter (Nihon Eido Co., Ltd., Tokyo, Japan). Next, the membranes were incubated with 1% (w/v) skim milk in TBS for 1 h and washed three times with TBS containing 0.02% Tween 20 (T-TBS). The membranes were then incubated with antiserum for 12 h at 4°C, washed three times with T-TBS, and incubated with horseradish peroxidase-conjugated anti-rabbit IgG for 1 h at room temperature. Finally, the membranes were washed three times with T-TBS and signals were observed using a SuperSignal West Pico Substrate peroxidase staining kit (Pierce, Rockford, IL), according to the manufacturer's instructions.
Protein oligomerization and dissociation
Oligomerization of recombinant enzymes produced in E. coli was assessed by gel fi ltration using a HiLoad 16/600 Superdex 200 pg column (GE Healthcare). The column was equilibrated with 50 mM phosphate buffer, pH 6.8, containing 150 mM NaCl. Proteins were eluted from the column at a fl ow rate of 1.0 ml/min at room temperature using a Waters 650 system (Waters Corp., Milford, MA). To induce oligomerization, proteins were preincubated with 2 mM ATP for 30 min at 37°C. The column was calibrated with gel fi ltration molecular weight markers (BioRad). Fractions were precipitated with 10% trichloroacetic acid and analyzed by Western blotting using anti-ACOT12 antibody. Band density was quantifi ed using the ChemiDoc XRS system (Bio-Rad).
Oligomerization and dissociation of recombinant proteins expressed in mammalian cells were assessed as follows. Hepa-1 cells, a murine-derived hepatoma cell line, were maintained in 5% CO 2 ( Fig. 3 ) , 45.3% of WT forms active tetramers, and 55.7% of THIO forms a mixture of active tetramer (31.8%) and dimer (23.9%) in the reaction. Considering proteins, enzyme activities were assayed at 5 min or less in subsequent experiments using a substrate concentration of 1 mM. As shown in Fig. 2D , the specifi c activity of the WT protein (74.4 ± 2.5 mol/mg/min) was about fi ve times higher than that of THIO (15.7 ± 0.4 mol/mg/min). START did not have enzymatic activity. Figure 2E shows a Lineweaver-Burk plot of WT and THIO at various column. As shown in Fig. 3A , when WT was applied to the column without preincubation with ATP, it was eluted from the column at an apparent molecular weight of 77 kDa, the expected molecular weight of a monomer. When WT was preincubated with ATP, a protein peak corresponding to an apparent molecular weight at 322 kDa was observed. This molecular weight is consistent with a tetramer. The peak areas of tetramer and monomer formation after ATP treatment were estimated to be 45.3% and 49.6%, respectively. As shown in Fig. 3B , THIO was eluted from the column at an apparent molecular weight of 44 kDa, consistent with a monomer. After preincubation with ATP, protein peaks corresponding to apparent molecular weights of 182 and 88 kDa were observed, consistent with a tetramer and a dimer formation, respectively. The peak areas of tetramer, dimer, and monomer formation after ATP treatment were 31.8%, 23.9%, and 43.1%, respectively. Therefore, about 56% of THIO forms active tetramer or dimer following treatment with ATP. These results indicate that almost half of WT or THIO proteins can form active oligomers in the presence of ATP. It should also be noted that THIO formed both dimers and tetramers, whereas WT formed only tetramers after treatment with ATP. These results also suggest that the START domain in ACOT12 is important for proper tetramer formation after dimer formation.
Effect of lipids on ACOT12 activity
The START domain is thought to act as a lipid binding, transferring, and sensing domain for phospholipids, sterols, and sphingolipids. With this in mind, we next tested the acetyl-CoA thioesterase activity of WT and THIO enzymes in the presence of various types of lipids (phospholipids, fatty acids, sphingolipids, and sterols) or G3P. Phospholipids were sonicated with a probe-type sonicator to form small unilamellar phospholipid vesicles, which were then added to the reaction mixture. Monomer or micellar forms of 1-oleoyl LPA, palmitic acid, or oleic acid were added to the reaction mixture. The critical micelle concentrations (CMCs) of 1-oleoyl LPA, palmitic acid, and oleic acid in the reaction were around 60, 4, and 6 M, respectively ( 25, 26 ) . Sterols were dissolved as cyclodextrin complexes and added to the reaction mixtures. As shown in Fig. 4A , the enzymatic activity of WT was dramatically inhibited by DOPA and egg yolk PA vesicles. These lipids showed inhibitory effects at a concentration of 1 M. 1-Oleoyl LPA at a concentration of 25, 100, or 500 M also had inhibitory effects. Because the CMC of 1-oleoyl LPA was around 60 M, it is thought that both monomer and micelle forms of 1-oleoyl LPA have inhibitory effects on WT. We found that 500 M of DMPG and oleic acid (micellar form) also inhibited WT activity. Other phospholipids, sphingolipids, and sterols had no signifi cant effects.
In contrast to what was observed for WT, the THIO fragment, which lacks a START domain, exhibited an increase in thioesterase activity following treatment with DOPA, egg PA, 1-oleoyl LPA, or DMPG ( Fig. 4B ) . Oleic acid at 500 M inhibited THIO similar to WT. Egg yolk PA, which has heterogeneous fatty acid residues in a diacylglycerol , respectively. Thus, V max and k cat values of THIO were reduced compared with those of WT. Therefore, the START domain is important for typical catalytic activity of the enzyme. In contrast, K m values of WT and THIO were the same. Thus, the START domain has little effect on the affi nity between ACOT12 and substrates.
We next analyzed the substrate specifi city of WT using various short carbon hydrate chains as provided by CoA compounds (1 mM). As shown in Fig. 2F , acetyl-CoA was the most favorable substrate, followed by butyryl-CoA and acetoacetyl-CoA. No hydrolysis was observed for HMG-CoA or octanoyl-CoA. Long chain acyl-CoA substrates such as palmitoyl-CoA and oleoyl-CoA, as well as malonyl-CoA, were also not hydrolyzed (data not shown). The apparent V max and K m values were as follows: acetoacetylCoA ( V max = 30.5 ± 3.9 mol/min/mg, K m = 0.33 ± 0.1 mM), and butyryl-CoA ( V max = 44.7 ± 4.0 mol/min/mg, K m = 0.41 ± 0.1 mM).
It was reported that ACOT12 usually forms oligomers (dimers or tetramers) at room temperature and is only active when it forms these oligomers ( 24 ) . In addition, ATP has been shown to induce tetramerization of ACOT12 ( 24 ) . To assess protein oligomerization, gel filtration was performed using a HiLoad 16/600 Superdex 200 pg of control values) following the addition of DOPA up to about 5 M ( Fig. 5B ) . 1-Oleoyl LPA also enhanced THIO activity under CMC. Although the LPA concentration increased more than the CMC, the enhancement of THIO activity by the lipid did not increase. These results suggest that monomer forms of LPA actually activate THIO activity than its micellar forms .
We next looked at the mechanism of inhibition of WT activity by DOPA. To address this, we performed kinetic experiments based on parameters obtained for thioesterase activity at various concentrations of acetyl-CoA in the absence or presence of DOPA (1, 2, and 4 M). As shown in Fig. 5C , a typical Michaelis-Menten curve was obtained when the initial velocity was plotted against the acetyl-CoA concentration. Lineweaver-Burk plots for the inhibition of DOPA are shown in Fig. 5D . V max , K m , and V max / K m are also shown in Table 1 . Both V max and V max / K m values decreased in a DOPA concentration-dependent manner, whereas K m values were nearly constant. These results clearly indicate that DOPA is a noncompetitive inhibitor of WT thioesterase activity. The slope ( K m / V max ) was plotted against inhibitor concentration ( Fig. 5D , inset) . The apparent Ki value for DOPA was estimated to be 0.50 ± 0.11 M.
Interaction of ACOT12 with PA
Because PA is a noncompetitive inhibitor, it can interact with an allosteric site of ACOT12 that is distinct from the moiety, was as effective as DOPA. In contrast, DOPC, which has the same diacylglycerol moiety as DOPA, did not show signifi cant effects on either enzyme. G3P also did not show any signifi cant effects. These results indicate that the head moiety, possibly the phosphate group of PA or LPA, and hydrophobicity of at least one acyl chain are important for enzymatic regulation of WT and THIO.
To assess the contribution of the START domain on ACOT12 activity, we next investigated the enzymatic activity of THIO in the presence or absence of isolated START protein. If the isolated START protein is effi cient, THIO activity should be activated ( Fig. 2E ) , or inhibited by DOPA similar to WT. However, no signifi cant change was observed (supplementary Fig. I) .
We next explored the enzymatic properties of the inhibition of WT activity by DOPA and 1-oleoyl LPA. As shown in Fig. 5A , WT activity could be inhibited robustly (20% of control levels) with addition of only 3 M DOPA. WT activity was also inhibited by 1-oleoyl LPA. Inhibition of WT with 1-oleoyl LPA was less robust than inhibition by DOPA. WT activity was strongly inhibited by the addition of the monomer form of 1-oleoyl LPA and less inhibition was observed for a micellar form of the lipid; i.e., maximum inhibition by LPA was obtained at a concentration lower than its CMC (60 M). The half-maximal inhibitory concentration (IC50) was 1.2 M for DOPA and 16.1 M for 1-oleoyl LPA ( Fig. 5A ) . In contrast, acetyl-CoA thioesterase activity of THIO activity was signifi cantly enhanced (almost 200% thioesterase domain is essential for a direct interaction with PA. We subsequently asked if acetyl-CoA interferes with the interaction between ACOT12 and PA. ACOT12-bound DOPA beads were incubated with the indicated concentrations of acetyl-CoA. As shown in Fig. 6C , the ACOT12-DOPA interaction was not affected by acetyl-CoA, suggesting that the binding site for PA is different from that for acetyl-CoA. This is consistent with the fi nding that the enzymatic activity of ACOT12 is inhibited by PA allosterically and in a noncompetitive manner.
ACOT12 oligomerization and dissociation
Next, we investigated the effect of PA on ACOT12 dissociation. We prepared a protein complex of 3xFlag-ACOT12 and V5-ACOT12, and analyzed the effects of PA on its interaction with ACOT12. Briefl y, both 3xFlag-tagged protein and V5-tagged protein were cotransfected into Hepa-1 cells, and 3xFlag-protein was immunoprecipitated with anti-Flag antibody-conjugated agarose beads at room temperature. Then, V5-tagged proteins that coimmunoprecipitated with Flag-tagged proteins were detected by immunoblotting with anti-V5 antibody. As shown in Fig. 7A , V5-WT coprecipitated with 3xFlag-WT. Addition of DOPA to the V5-and 3xFlag-tagged protein complexes did not show any signifi cant effects on dissociation . It has been reported that ACOT12 dissociates into an inactive monomer when incubated at low temperature ( 24 ) . substrate binding site. We next assessed lipid-protein interactions between PA and ACOT12 using butyl-Sepharose beads conjugated to DOPC or DOPA. Purifi ed WT, THIO, or START proteins were mixed with DOPC-or DOPAconjugated beads and incubated for 30 min at room temperature to allow for binding. Proteins bound to the beads were then pelleted (beads), and both these and proteins remaining in the supernatant were analyzed by immunoblotting using an anti-ACOT12 antibody. The results clearly demonstrated that both the WT and THIO proteins could specifi cally bind to DOPA-conjugated beads, although both showed nonspecifi c weak binding to the control and DOPC-conjugated beads ( Fig. 6A ) . START could not interact with PA-conjugated beads. These results are in good agreement with the level of enzyme activity in the supernatant ( Fig. 6B ) . These results suggest that the N-terminal 
Transcriptional regulation of hepatic ACOT12 by insulin
Because ACOT12 is the major enzyme known to hydrolyze cytosolic acetyl-CoA in the liver, which is essential for lipid biosynthesis, we reasoned that transcription of ACOT12 might be regulated by hormones involved in energy homeostasis. To investigate this, we next analyzed the effects of insulin on ACOT12 mRNA levels. We used rat Consistent with this, we found that if the beads were incubated on ice, V5-WT dissociated from the beads and eluted with the supernatant. These results indicate that the inhibition of ACOT12 by PA is not due to disruption of protein oligomers.
We next analyzed protein interactions between 3xFlag-WT and V5-THIO or 3xFlag-THIO and V5-THIO. As shown in Fig. 7B , V5-THIO coimmunoprecipitated with 3xFlag-WT and 3xFlag-THIO. This indicates that the THIO domain, not the START domain, is necessary for ACOT12 oligomerization. The addition of DOPA did not disrupt WT-THIO or THIO-THIO protein interactions.
Detection of ACOT12 protein in rat tissues or cultured hepatic cell lines
To determine if ACOT12 protein is present in various tissues, we generated anti-ACOT12 antisera and performed immunoblot analysis with a variety of rat tissues. As shown in Fig. 8A , ACOT12 is detected at high levels in the liver, with the next highest intensity of staining detected in the kidney and the intestine. The presence of ACOT12 was also assayed in the following hepatic cell lines: Fa2N-4 (an SV40 immortalized human hepatocyte cell line), Hepa-1 (a murine-derived hepatoma cell line), and HepG2 (a human liver carcinoma cell line) ( Fig. 8B ) . Despite the fact that ACOT12 protein was detectable in liver tissue, Values are shown as the mean ± SD (n = 3). * P < 0.001 as compared with control. C: ACOT12-bound DOPA beads were incubated with the indicated concentration of acetyl-CoA, and proteins bound to the beads (Beads) or in the supernatant (Sup) after centrifugation were analyzed by immunoblotting using an anti-ACOT12 antibody. . Protein complexes were immunoprecipitated using anti-Flag antibodyconjugated beads at room temperature. After beads were washed and incubated with TBS containing 100 M DOPA at room temperature or with TBS on ice for 60 min, proteins bound to the beads (Ppt) or dissociated into the supernatant (Sup) were analyzed using anti-Flag or anti-V5 antibodies. IP, immunoprecipitation; WB, Western blot. of day 6 cells with clofi brate, although no visible increase of ACOT12 protein was observed.
DISCUSSION
Cytosolic acetyl-CoA is the starting compound for biosynthesis of both fatty acids and cholesterol. Because ACOT12 appears to be the major enzyme responsible for determining the rate of degradation of cytosolic acetyl-CoA in the liver, the enzymatic and transcriptional regulation of ACOT12 is important for the control of lipid biosynthesis. After screening with several types of lipids here, we determined that the enzymatic activity of ACOT12 is inhibited by PA in vitro in a noncompetitive manner. The results clearly show that the START domain of ACOT12 plays an important role in the inhibitory effects of PA, as enzyme activity of THIO, which does not contain the START domain, was enhanced rather than inhibited by PA ( Figs. 4, 5 ) . Although START domains have been thought to be involved in binding, transferring, and sensing lipids, the START domain of ACOT12 does not appear bind to PA, whereas our data show that THIO, a catalytic domain of ACOT12, is essential for PA binding ( Fig. 6 ). As shown in Fig. 2E , K m values of WT and THIO were the same. Thus, the START domain has little effect on the affi nity between ACOT12 and substrates. On the other hand, V max and primary hepatocytes, as based on the results of our immunoblot analysis; hepatic cell lines do not appear to express ACOT12 protein. The mRNA and protein levels of ACOT12 of freshly isolated primary hepatocytes before plating, indicated as day 0, and the cells cultured for the day indicated (day 1, 2, 4, or 6) in the presence or absence of FBS, were analyzed by quantitative PCR and immunoblotting, respectively . As shown in Fig. 9A , ACOT12 mRNA of day 0 was drastically decreased after plating. The ACOT12 mRNA at day 1 was about 2% of day 0. ACOT12 mRNA levels were continuously decreased over time. As shown in Fig. 9B , the protein levels of ACOT12 were also decreased in good accordance with mRNA expression, and ACOT12 expression was not preserved by FBS treatment. Thus, we decided to use primary hepatocytes at day 1 to analyze hormonal control. As shown in Fig. 9C, D , a signifi cant decrease in ACOT12 mRNA and protein levels was observed following treatment with insulin (100 nM). It was previously reported that subcutaneous injection of clofi brate increased ACOT12 activity in the rat liver ( 14 ) . We confi rmed that treatment of rat hepatocytes at day 1 with this drug in vitro also increased both ACOT12 mRNA and protein levels ( Fig. 9E, F ) . Next, we investigated whether the drug can also enhance ACOT12 mRNA expression of cells at day 6. As shown in supplementary Fig. II , the level of ACOT12 mRNA was increased about 1.6-fold by treatment Fig. 9 . Transcriptional regulation of ACOT12 in rat hepatocytes. Rat primary hepatocytes were fi rst cultured with 10% FBS and 1 M of dexamethasone and insulin. Then, 4 h after plating, cells were cultured for the indicated number of days in Williams' medium E without insulin and dexamethasone in the presence (+) or absence ( Ϫ ) of 10% FBS. Finally, the levels of ACOT12 mRNA (A) and protein (B) were determined by quantitative PCR and immunoblot analysis, respectively. Day 0 means freshly isolated hepatocytes before plating. ␤ -Actin was used as a loading control (Cont). * P < 0.001 as compared with day 0 cells. Rat primary hepatocytes (day 1) cultured without FBS were incubated with or without 100 nM insulin (C, D) or 100 M clofi brate (E, F) for the time indicated. Finally, the levels of ACOT12 mRNA (C, E) and protein (D, F) were determined. Values are shown as the mean ± SD from three independent culture dishes. *P < 0.05 and ** P < 0.001 as compared with control cells incubated with vehicle. k cat values of THIO were reduced compared with those of WT. Therefore, the START domain is important for typical catalytic activity of the enzyme.
Oligomerization is important for enzymatic activity of ACOT12 ( 9, 20 ) . In this study, we showed that the THIO domain is necessary for proper oligomerization and that ACOT12 oligomers are not disrupted following the addition of PA ( Fig. 7 ) . The results of our gel fi ltration study clearly show that WT forms tetramers after ATP treatment whereas THIO forms both dimers and tetramers ( Fig. 3 ) . This suggests that the START domain of ACOT12 is important to facilitate the formation of tetramer. The detailed mechanisms underlying how the START domain affects enzyme activity or oligomerization have yet to be fully characterized. Nevertheless, it seems reasonable to propose that the START domain might modulate the whole enzyme and/or the active site, for example by interacting with PA at the N-terminal catalytic domain.
There are 12 ACOT protein family members in the mouse. Based on structure predictions, fi ve of these can be placed in the hotdog-fold enzyme superfamily ( 7, 15, 27 ) . Among these, ACOT13, also known as thioesterase superfamily member 2, contains a 140 amino acid hotdog-fold thioesterase domain, and interestingly, its enzymatic activity can be inhibited by PC vesicles ( 28 ) . Moreover, addition of PA to PC vesicles reportedly led to a more signifi cant inhibitory effect (molar ratio of PA/PC, 0.2 or 0.3) on enzymatic activity than addition of vesicles containing only PC. Additionally, binding of ACOT13 to PC vesicles increased with increasing PA content in PC vesicles. Thus, PA shows similar inhibitory effects on the enzymatic activity of both ACOT12 and ACOT13, although PC was not effective with ACOT12. It will be interesting to determine if the enzymatic activity of other members of the hotdogfold thioesterase superfamily can also be inhibited by PA and whether or not they bind to PA.
The thioesterase activity of ACOT11, known as thioesterase superfamily member 1 or StarD14, another hotdog-fold ACOT member with a C-terminal START domain, was recently characterized ( 29 ) . This enzyme preferentially hydrolyzes long chain acyl-CoA compounds such as palmitoyl-CoA and myristoyl-CoA. An ACOT11 mutant lacking the START domain showed a higher K m value and lower V max value with long chain acyl-CoA than intact ACOT11. Interestingly, mixing the mutant with the deleted START domain led to reduced K m and increased V max values, close to what was observed for intact ACOT11. It was also reported that the enzymatic activity of ACOT13 was increased by PC-transfer protein, which consists entirely of a START domain ( 30 ) . We do not yet have a detailed understanding of how START domain-containing proteins facilitate enzymatic activity of ACOT11 or ACOT13. However, we have shown that the enzymatic activity of THIO, a mutant form of ACOT12 lacking the START domain, did not change in the presence of deleted START domain (supplementary Fig. I ). Thus, we suggest that although the START domains in ACOT11 and ACOT12 are each important for optimal thioesterase activity, their specifi c roles or mechanisms of action might be different. Supplemental Material can be found at:
